Opsonix
Developing a broad-spectrum pathogen-extracting therapy to transform the treatment of sepsis.
Launch date
Employees
Market cap
-
Enterprise valuation
€29—44m (Dealroom.co estimates Oct 2015.)
Cambridge Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$8.0m | Series A | ||
Total Funding | €7.3m |
Recent News about Opsonix
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.